Innovations in Heart Failure: Highlights and Insights From AHA 2021*

Download All
November 13-15, 2021; Virtual
Review the latest data on managing heart failure with Capsule Summaries and expert-authored commentaries covering key studies from AHA 2021.
Lee R. Goldberg, MD, MPH, FACC

ClinicalThought

At AHA 2021, some major clinical trials broke new ground with familiar agents while others validated management approaches previously informed largely by clinical experience. Here’s my take.

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 8, 2021 Expired: December 7, 2022

Here are my thoughts on the exciting studies of novel therapies in heart failure, including a myosin inhibitor, statin use, and electrical cardioversion for atrial fibrillation.

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 9, 2021 Expired: December 8, 2022

At AHA 2021, new data on the use of telehealth platforms demonstrated that video visits are a feasible approach to managing patients with heart failure.

Lee R. Goldberg, MD, MPH, FACC Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 13, 2021 Expired: December 12, 2022
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Merck

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings